Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enzalutamide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02485691
What this trial is testing

Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent

Who this might be right for
Prostate Cancer Metastatic
Sanofi 255
Testing effectiveness (Phase 2)Active Not RecruitingNCT02955394
What this trial is testing

Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer

Who this might be right for
Breast Cancer
University of Colorado, Denver 61
Large-scale testing (Phase 3)Active Not RecruitingNCT03395197
What this trial is testing

Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC

Who this might be right for
mCRPC
Pfizer 1,054
Large-scale testing (Phase 3)Study completedNCT04191096
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer
Merck Sharp & Dohme LLC 1,251
Testing effectiveness (Phase 2)Ended earlyNCT02555189
What this trial is testing

Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaProstate Carcinoma Metastatic in the Bone+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 52
Early research (Phase 1)Ended earlyNCT05252390
What this trial is testing

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorOvarian CancerOvary Cancer+24 more
Nuvation Bio Inc. 82
Post-approval studies (Phase 4)Study completedNCT02116582
What this trial is testing

Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Astellas Pharma Europe B.V. 215
Early research (Phase 1)WithdrawnNCT02380313
What this trial is testing

Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone

Who this might be right for
Cancer
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT02407054
What this trial is testing

Enzalutamide and LY3023414 in Men With Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Eli Lilly and Company 142
Large-scale testing (Phase 3)Looking for participantsNCT07028853
What this trial is testing

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Who this might be right for
Metastatic Castration Sensitive Prostate Cancer (mCSPC)Hormone Sensitive Prostate CancerProstate Cancer+1 more
Pfizer 1,000
Not applicableStudy completedNCT02663193
What this trial is testing

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

Who this might be right for
Prostate Cancer
Janssen Scientific Affairs, LLC 108
Testing effectiveness (Phase 2)Study completedNCT02099864
What this trial is testing

Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Neoplasm in the Soft Tissues+4 more
OHSU Knight Cancer Institute 36
Testing effectiveness (Phase 2)Study completedNCT01288911
What this trial is testing

Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Astellas Pharma Inc 375
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262154
What this trial is testing

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT02215161
What this trial is testing

Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneHormone-Resistant Prostate CancerMetastatic Prostate Carcinoma in the Soft Tissue+3 more
University of California, San Francisco 14
Testing effectiveness (Phase 2)Looking for participantsNCT06096870
What this trial is testing

Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

Who this might be right for
Prostate CancerRecurrent Prostate CancerPET Positive
National Cancer Institute (NCI) 65
Testing effectiveness (Phase 2)Study completedNCT05114746
What this trial is testing

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 94
Early research (Phase 1)Study completedNCT04628988
What this trial is testing

CC-90011 and Comparators in Participants With Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Celgene 6
Early research (Phase 1)Ended earlyNCT03300505
What this trial is testing

ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 9
Post-approval studies (Phase 4)Study completedNCT01977651
What this trial is testing

Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Astellas Pharma Global Development, Inc. 424
Next Page